When To Operate for Endometrial Hyperplasia
|
|
- Christal McDaniel
- 5 years ago
- Views:
Transcription
1 When To Operate for Endometrial Hyperplasia David Scott Miller, M.D., F.A.C.O.G., F.A.C.S. Amy and Vernon E. Faulconer Distinguished Chair in Medical Science Director and Dallas Foundation Chair in Gynecologic Oncology Professor of Obstetrics & Gynecology University of Texas Southwestern Medical Center at Dallas
2 Learning Objectives Identify patients at risk for endometrial hyperplasia Incorporate into practice contemporary medical and surgical standards of care for endometrial hyperplasia Prevent endometrial cancer
3 Defining Menopause & Perimenopause A woman s lifetime Perimenopause First signs of change Menopause Diagnosed 12 months retrospectively NAMS. Menopause Curriculum Study Guide Utian, WH. Menopause
4 Endometrial Cancer
5 US Mortality, 2006 Rank Cause of Death No. of deaths % of all deaths 1. Heart Diseases 631, Cancer 559, Cerebrovascular diseases 137, Chronic lower respiratory diseases 124, Accidents (unintentional injuries) 121, Diabetes mellitus 72, Alzheimer disease 72, Influenza & pneumonia 56, Nephritis* 45, Septicemia 34, *Includes nephrotic syndrome and nephrosis. Source: US Mortality Data 2006, National Center for Health Statistics, Centers for Disease Control and Prevention, 2009.
6
7 CA: A Cancer Journal for Clinicians. Volume 62, Issue 1, pages 10-29, 4 JAN 2012 DOI: /caac
8 Cancer Incidence Rates* Among Women, US, Rate Per 100, Breast Colon and rectum Lung & bronchus Uterine Corpus Ovary Non-Hodgkin lymphoma *Age-adjusted to the 2000 US standard population and adjusted for delays in reporting. Source: Surveillance, Epidemiology, and End Results Program, Delay-adjusted Incidence database: SEER Incidence Delay-adjusted Rates, 9 Registries, , National Cancer Institute, 2008.
9 Cancer Death Rates* Among Women, US, Rate Per 100, Uterus Breast Lung & bronchus 20 Stomach Colon & rectum Ovary 0 Pancreas *Age-adjusted to the 2000 US standard population. Source: US Mortality Data , US Mortality Volumes , National Center for Health Statistics, Centers for Disease Control and Prevention, 2008.
10 Cancer Sites in Women for Which African American Death Rates* Exceed White Death Rates*, US, Site African American White Ratio of African American/White All sites Stomach Myeloma Uterine cervix Esophagus Uterine corpus Small intestine Larynx Colon and rectum Pancreas Breast Gallbladder Urinary bladder Liver and intrahepatic bile duct *Per 100,000, age-adjusted to the 2000 US standard population. Source: Surveillance, Epidemiology, and End Results Program, , Division of Cancer Control and Population Sciences, National Cancer Institute, 2008.
11 Epidemiology Known cancer causes Occupational exposure Lifestyle factors Biologic agents Iatrogenic factors Genetic mutations Trichopoulos D, et al. Cancer: Principles & Practice of Oncology. 5th ed. 1997;
12 Epidemiology Genetic risk factors: mechanisms of cancer predisposition Germline tumor suppressor gene inactivation Germline oncogene activation DNA repair defects Ecogenetic traits Bale AE, Li FP. Cancer: Principles & Practice of Oncology. 5th ed. 1997;
13 Endometrial Cancer: Annual Incidence and Mortality ACS Estimates Year Cases Deaths ,000 2, ,130 8,010 American Cancer Society 2012
14 Endometrial Cancer: Risk Factors Characteristic Obesity >30 LBS >50 LBS Nulliparous Late Menopause Unopposed Estrogen Atypical Hyperplasia Diabetes Hypertension Relative Risk [X]
15
16
17
18 Risk of Endometrial Cancer With ERT and HRT Cyclic and Continuous <5 Years RR (95% CI) >5 Years RR (95% CI) ERT HRT (cyclic) HRT (continuous) 2.0* ( ) 1.5 ( ) 0.8 ( ) 7.5* ( ) 2.9*( ) 0.2*( ) *CI do not include 1.0. Weiderpass E et al. J Natl Cancer Inst. 1999;91:
19 Endometrial Tumorigenesis Cellular milieu Stem Cell Genetic predisposition?? Multiple Genetic Insults (mutations) PTEN, TP53, KRAS2, other events?? Atypical hyperplasia Loss of DNA mismatch repair Adenocarcinoma
20 HNPCC Increases Colorectal and Endometrial Cancer Risks Up to 80% General Population HNPCC Risk of Cancer (%) >25% 20% Up to 71% 0 0.2% CRC by age 50 2% CRC by age % 1.5% EC by age 50 EC by age 70 Gastroenterology 1996;110: Int J Cancer 1999;81:214-8 Gastroenterology 2004;127:17-25
21
22 In Summary: 1. Screen for Red Flags Multiple colorectal adenomas Colorectal cancer before age 50 Endometrial cancer before age 50 Two or more HNPCC-related cancers in an individual or family 2. Discuss genetic testing options 3. Establish appropriate medical management plan
23 Endometrial Cancer: Types Type I Estrogen Related Younger and heavier patients Low grade Perimenopausal Exogenous estrogen Type II Aggressive Unrelated to estrogen stimulation Occurs in older & thinner women Potential genetic basis
24 Endometrial Cancer: Types
25 Endometrial hyperplasia Simple hyperplasia Risk for Carcinoma without atypia 1% with atypia 8% Complex hyperplasia without atypia 3% with atypia 29% Kurman et al. Cancer 56:403 85
26 Cancer Risk In Endometrial Hyperplasia Nested case control study at Kaiser. N = 194 Median interval of EH to Ca 6.7 yrs CAH (OR=20.6, 95% CI, ) CH (OR=0.8, 95% CI, ) SH (OR=1.7, 95% CI, ) CAH diagnoses were associated with substantially increased endometrial carcinoma risk, which persisted for over 5 years. Risks associated with SH and CH were similar to those for DPEM Lacey et al. AACR 2007, #4294
27 Atypical Endometrial Hyperplasia AEH dx not confirmed in 61% Ca found in 40% (31% > IA GI) 37% in confirmed AEH 67% with no agreement Zaino et al. Cancer 106: Trimble et al. Cancer 106:812 06
28 EIN and WHO94 Baak & Mutter. J Clin Pathol. 58:1 05
29 EIN vs. WHO Baak et al. Cancer 103:
30 Endometrial Cancer: Screening Patient Primary* Cytology Not satisfactory Histology - Secondary Hysteroscopy Not satisfactory Sonography Cost-effective issue *Patient/physician awareness
31 OMINOUS SIGNS Any bleeding from the genital tract of a woman which occurs after a period of amenorrhoea lasting 6 months or longer at the age of the menopause is regarded a postmenopausal bleeding Menstruation in a woman older than 55 yr Abnormal bleeding at ± menopause
32 Postmenopausal bleeding Definition: bleeding that occurs after 12 months of amenorrhea Sources: Uterine corpus: Endometrial atrophy, endometritis, polyp, endometrial hyperplasia, cancer, sarcoma Uterine Cervix: Polyp, cervicitis, cancer Vagina: Atrophy, infection, cancer, trauma, foreign body Vulva Ulcerations, excoriations, trauma, cancer Urinary tract Urethral caruncle, urethral mucosal prolapse, hematuria Gastrointestinal tract Rectal polyp, hemorrhoids, hematochezia, Other: Metastases, oviduct cancer, endometriosis, Systemic illness Coagulation disorder, hepatic cirrhosis Iatrogenic Anticoagulation, estrogen therapy
33 Postmenopausal Uterine Bleeding 10% of women with postmenopausal bleeding will be diagnosed with endometrial cancer and an equal number with hyperplasia. 1 PMB incurs a 64-fold increased risk for developing endometrial CA.² ¹Karlsson, et al. AJOG 172: ²Gull, et al. AJOG 188:401 03
34 Diagnosis of disease: Patient Awareness* More than 95% of patients with Endometrial Cancer report having symptoms Postmenopausal bleeding Menorrhagia Metrorrhagia Bloody Discharge Endometrial biopsy is the main diagnostic tool performed either in the office or via D&C in OR
35 Post menopausal bleeding ETIOLOGY (%) Exogenous estrogen 30 Atrophy (uterus/vag) 30 Endo. Ca. 15 Polyps 10 Hyperplasia 5 Miscellaneous 10
36 Postmenopausal bleeding Histology Office procedure (Accurette, Pipelle, etc) Formal dilation and curettage Hysteroscopy
37 Numerous sampling devices available Easy to perform Sensitivity 90-95% EMB
38 Endometrial Biopsy
39 Who Needs an Endometrial Biopsy? Postmenopausal bleeding Postmenopausal women with atypical glandular cells on Pap Perimenopausal intermenstrual bleeding Abnormal bleeding with history of anovulation Thickened endometrial stripe via sonography
40 Leitao et al. Gyn Onc 113: Comparison of D&C vs EMB
41 Endometrial Cancer: Transvaginal Ultrasound N=250 Diagnosis <5m m Endometrial Stripe Thickness 6-10mm 11-15m m >15m m Atrophy 93% 7% Hyperplasia 58% 42% Polyp 53% 47% Cancer 18% 41% 41% Grigoriou: Maturitus 23:9-14,1996
42 ACOG. Ob Gyn 114:409 09
43 Thin Edometrium
44 Saline-Infusion Sonography Endometrial Sampling Moschos et al. Ob Gyn 113:881 09
45 TVS & EMB for PMB Hanegem et al. Maturitas 68:155 11
46 3D Techniques For Endometrial Hyperplasia & Cancer best predictor of endometrial carcinoma was an endometrial volume of 3.56 cc or more (sensitivity 93.1%, specificity 36.2%) Odeh et al. Gyn Onc 106:348 07
47 Hysteroscopy
48 Accuracy of Hysteroscopy Systematic Quantitative Review of Endometrial Cancer & Hyperplasia Sixty-five primary studies were analyzed, including 26,346 women Positive hysteroscopy result (pooled LR, 60.9; 95% CI, ) increased the probability of cancer to 71.8% (95% CI, 67.0%-76.6%), whereas a Negative hysteroscopy result (pooled LR, 0.15; 95% CI, ) reduced the probability of cancer to 0.6% (95% CI, 0.5%- 0.8%) diagnostic accuracy of hysteroscopy is high for endometrial cancer Clark et al. JAMA 288:
49 PMB: Cost-Effectiveness USS using a 5-mm cutoff was the least expensive Conclusion: PMB should undergo initial evaluation with USS or EB Clark et al. BJOG 113:502 06
50 PMB Recommendations PMB requires assessment to exclude cancer by US or EMB Insufficient EMB requires further evaluation <4mm endometrial stripe does not require EMB >4mm requires further evaluation Unsatisfactory US requires further evaluation Recurrent/persistant PMB requires further evaluation Asymptomatic >4mm requires no further evaluation ACOG. Ob Gyn 114:409 09
51 Comparison of Relative Risks with Tamoxifen Therapy vs. Placebo: NSABP P-1 Fisher et al. JNCI (2005) 97;1652.
52 Tamoxifen and endometrial pathology: to screen or not to screen with TVU? Mean age Duration of Tamoxifen Mean EEC Benign Endometrium 51.8 yrs (+ 10.1) 33.1 mos ( mos) 7.6 mm (+ 3.9) Endometrial Hyperplasia/Ca 50 yrs (+ 7.5) 23 mos ( mos) 8.8 mm (+ 5.0) Median EEC 7 mm 7 mm P value Premenopausal EEC Post menopausal EEC 8.1 mm (+ 3.4) 7.6 mm (+ 4.7) 9.5 mm 0.5 (+ 5.4) 6.0 mm 0.7
53 Tamoxifen and Endometrial Pathology ACOG recommendations Any abnormal uterine bleeding should be investigated in women taking tamoxifen Screening procedures in women with breast cancer undertaking tamoxifen therapy should be performed at the discretion of the gynecologist ACOG. Ob Gyn 107:
54 TVS Doubilet, et al. Menopause 18:421 11
55 EMB Doubilet, et al. Menopause 18:421 11
56 Endometrial Hyperplasia Hyperplasia: without atypia continuous progesterone treatment (e.g. medroxyprogesterone acetate 5 mg daily for three months) followed by repeat histology if normal then, consider hormone replacement therapy
57 Endometrial Hyperplasia Hyperplasia: with atypia Total abdominal hysterectomy and bilateral salpingo-oophorectomy advised
58 Conservative Treatment For Young Women With Atypical Endometrial Hyperplasia Or Adenocarcinoma Jadoul et al. Fert Ster 80:
59 Thermal balloon
60
61 Endometrial Ablation Methods
62 ACOG. Endometrial ablation Practice Bulletin #81 Obstet Gynecol 109: Endometrial Ablation
63
64 Mirena And Endometrial Hyperplasia a 3-month study with Mirena vs historical group treated with systemic MPA Treatment of hyperplasia assessed by light microscopy and nuclear morphometric analysis Regression of hyperplasia was observed in 100% of Mirena cases vs 45% treated with MPA Reduction in nuclear size observed with both treatments More obvious in Mirena group in hyperplasia patients with the highest malignant potential (D score = 0 1) a Mirena is not currently licensed for this indication Vereide et al. Gynecol Oncol 2003;92:526 33
65 Endometrial Cancer: Surgical Staging Conceptual rationale Defines extent of disease Minimizes over/under treatment Minimally increases perioperative morbidity/mortality Decreases overall Rx risks and costs Allows comparison of therapeutic results
66 Endometrial Cancer: Nodal Involvement Situation % Positive Nodes G1, no myometrial invasion, no extrauterine disease. <1% G2 or G3, inner 1/3 invasion, no extrauterine disease 5-9% Pelvic 4% Aortic G3, outer muscle, and/or extrauterine disease 20-60% Pelvic 10-30% Aortic
67 Endometrial Cancer: Surgical Approach TAH-BSO/washings only Grades 1, 2* < 50% myometrial invasion* Endometrioid* < 2 cm tumor diameter* *Verified via frozen section
68 Endometrial Cancer: Surgical Approach Complete Surgical Staging* Grade 3 > 50% myometrial invasion >2 cm tumor diameter Serous/clear cell subtypes Advanced stages *TAH-BSO, washings, lymphadenectomy, omental/peritoneal biopsy
69 Laparoscopic Surgical Staging: GOG LAP-II Trial N = 1500 (Goal: 2550) Open: 4/96 Adenocarcinoma or sarcoma Phase III & Quality of Life Stage I/IIA Grade I-III Any Quetelet Index Laparotomy TAH/BSO Surgical Staging Cytology Laparoscopy LAVH/BSO Surgical Staging Cytology
70 Endometrial Cancer: FIGO Surgical Stage
71 Endometrial Cancer: FIGO Surgical Stage
72
73 GOG #99 Conclusion: strong evidence for RT in high intermediate risk. not recommended for lower risk Take home: RT will cut recurrence from 27% to 13%, death from 26% to 12% in HIR But, increase toxicity 6% to 14% Thus, 100 patients will be treated to benefit 14 Keys et al. Gyn Onc 92:744 04
74 GOG #153: Phase II Alternating Megestrol Tamoxifen for Recurrent or Persistent Endometrial Cancer MEG 80 mg po bid X 3 wks TMX 20 mg po bid X 3 wks 7/94-11/95, n = 56 G 3/4 vascular toxicity = 7% CR 21% + PR 5% = 27% (90% CI: 17-38%), 53% >20 mo. Grade 1-3 ORR: 38, 24, 22% PFS = 2.7, OS = 14, DOR = 28 MO. active... may offer a prolonged complete response Fiorica et al. Gyn Onc 92:10 04
75 Endometrial Cancer: Single Agent Chemotherapy Response Rates Agent Response Agent Response Paclitaxel 37% HMM 17% Carboplatin 28% Vincristine 16% Doxorubicin 26% Etoposide 14% Cisplatin 25% Ifosfamide 14% 5-FU 21% Cytoxan 11% GOG Symposium July 1999 Goff
76
77 Endometrial Cancer: Survival by Surgical Stage
78
Management of Endometrial Hyperplasia
Management of Endometrial Hyperplasia I have nothing to disclose. Stefanie M. Ueda, M.D. Assistant Clinical Professor UCSF Division of Gynecologic Oncology Female Malignancies in the United States New
More information3/25/2019. Rare uterine cancers ~3% Leiomyosarcoma Carcinosarcoma (MMMT) Endometrial Stromal Sarcomas Aggressive tumors High Mortality Rates
J. Anthony Rakowski D.O., F.A.C.O.O.G. MSU SCS Board Review Coarse Rare uterine cancers ~3% Leiomyosarcoma Carcinosarcoma (MMMT) Endometrial Stromal Sarcomas Aggressive tumors High Mortality Rates Signs
More informationEndometrial Cancer. Incidence. Types 3/25/2019
Endometrial Cancer J. Anthony Rakowski DO, FACOOG MSU SCS Board Review Coarse Incidence 53,630 new cases yearly 8,590 deaths yearly 4 th most common malignancy in women worldwide Most common GYN malignancy
More informationNew Cancer Cases By Site Breast 28% Lung 14% Colo-Rectal 10% Uterus 6% Thyroid 5% Lymphoma 4% Ovary 3%
Uterine Malignancy New Cancer Cases By Site 2010 Breast 28% Lung 14% Colo-Rectal 10% Uterus 6% Thyroid 5% Lymphoma 4% Ovary 3% Cancer Deaths By Site 2010 Lung 26% Breast 15% Colo-Rectal 9% Pancreas 7%
More informationIndex. B Bilateral salpingo-oophorectomy (BSO), 69
A Advanced stage endometrial cancer diagnosis, 92 lymph node metastasis, 92 multivariate analysis, 92 myometrial invasion, 92 prognostic factors FIGO stage, 94 histological grade, 94, 95 histologic cell
More informationUpdates in Gynecologic Oncology. Todd Boren, MD Gynecologic Oncologist Chattanooga s Program in Women s Oncology Sept 8 th, 2018
Updates in Gynecologic Oncology Todd Boren, MD Gynecologic Oncologist Chattanooga s Program in Women s Oncology Sept 8 th, 2018 COI I have no conflict of interest to report Endometrial Cancer: Risk Factors
More informationHitting the High Points Gynecologic Oncology Review
Hitting the High Points is designed to cover exam-based material, from preinvasive neoplasms of the female genital tract to the presentation, diagnosis and treatment, including surgery, chemotherapy, and
More informationEndometrial Cancer Biopsy of the endometrium Evaluation of women of all ages
Endometrial Cancer Biopsy of the endometrium Evaluation of women of all ages Barbara S. Apgar, MD, MS Professor of Family Medicine University of Michigan Health System Ann Arbor, Michigan Cancer of the
More informationMolly A. Brewer DVM, MD, MS Chair and Professor Department of Obstetrics and Gynecology University of Connecticut School of Medicine
Molly A. Brewer DVM, MD, MS Chair and Professor Department of Obstetrics and Gynecology University of Connecticut School of Medicine Review causes of abnormal uterine bleeding: Adolescent Reproductive
More informationGynecologic Cancers are many diseases. Gynecologic Cancers in the Age of Precision Medicine Advances in Internal Medicine. Speaker Disclosure:
Gynecologic Cancer Care in the Age of Precision Medicine Gynecologic Cancers in the Age of Precision Medicine Advances in Internal Medicine Lee-may Chen, MD Department of Obstetrics, Gynecology & Reproductive
More informationGynecologic Cancers are many diseases. Speaker Disclosure: Gynecologic Cancer Care in the Age of Precision Medicine. Controversies in Women s Health
Gynecologic Cancer Care in the Age of Precision Medicine Gynecologic Cancers in the Age of Precision Medicine Controversies in Women s Health Lee-may Chen, MD Department of Obstetrics, Gynecology & Reproductive
More informationOne of the commonest gynecological cancers,especially in white Americans.
Gynaecology Dr. Rozhan Lecture 6 CARCINOMA OF THE ENDOMETRIUM One of the commonest gynecological cancers,especially in white Americans. It is a disease of postmenopausal women with a peak incidence in
More informationGynecologic Decision Making Based on Sonographic Findings
Gynecologic Decision Making Based on Sonographic Findings Mindy Goldman, MD Department of Obstetrics & Gynecology & Vickie A. Feldstein, MD Department of Radiology University of California, San Francisco
More informationSarah Burton. Lead Gynae Oncology Nurse Specialist Cancer Care Cymru
Sarah Burton Lead Gynae Oncology Nurse Specialist Cancer Care Cymru Gynaecological Cancers Cervical Cancers Risk factors Presentation Early sexual activity Multiple sexual partners Smoking Human Papiloma
More informationEndometrial cancer. Szabolcs Máté MD. I. St. Department of Obstetrics and Gyneacology.
Endometrial cancer Szabolcs Máté MD. I. St. Department of Obstetrics and Gyneacology dr.mate.szabolcs@gmail.com Epidemiology Developing countries Cervical cancer is the most common gyn. malignant tumor
More information5/5/2010 FINANCIAL DISCLOSURE. Abnormal Uterine Bleeding. Is This A Problem? About me % of visits to gynecologist
Abnormal Uterine FINANCIAL DISCLOSURE I HAVE NO FINANCIAL INTEREST IN ANY OF THE PRODUCTS MENTIONED IN MY PRESENTATION Bryan K. Rone, M.D. University of Kentucky Obstetrics and Gynecology May 5, 2010 About
More information6 Week Course Agenda. Today s Agenda. Ovarian Cancer: Risk Factors. Winning the War 11/30/2016 on Women s Cancer Gynecologic Cancer Prevention
6 Week Course Agenda Winning the War 11/30/2016 on Women s Cancer Gynecologic Cancer Prevention Lee-may Chen, MD Director, Division of Gynecologic Oncology Professor Department of Obstetrics, Gynecology
More informationreceive adjuvant chemotherapy
Women with high h risk early stage endometrial cancer should receive adjuvant chemotherapy Michael Friedlander The Prince of Wales Cancer Centre and Royal Hospital for Women The Prince of Wales Cancer
More informationARRO Case: Early-stage Endometrial Cancer
ARRO Case: Early-stage Endometrial Cancer Ankit Modh, MD (PGY-4) Faculty Advisor: Mohamed A Elshaikh, MD Department of Radiation Oncology Henry Ford Cancer Institute Case Presentation 70 y/o African American
More informationPage # 1. Endometrium. Cellular Components. Anatomical Regions. Management of SIL Thomas C. Wright, Jr. Most common diseases:
Endometrium Pathology of the Endometrium Thomas C. Wright Columbia University, New York, NY Most common diseases: Abnormal uterine bleeding Inflammatory conditions Benign neoplasms Endometrial cancer Anatomical
More informationMPH Quiz. 1. How many primaries are present based on this pathology report? 2. What rule is this based on?
MPH Quiz Case 1 Surgical Pathology from hysterectomy performed July 11, 2007 Final Diagnosis: Uterus, resection: Endometrioid adenocarcinoma, Grade 1 involving most of endometrium, myometrial invasion
More informationFrequency of menses. Duration of menses 3 days to 7 days. Flow/amount of menses Average blood loss with menstruation is 60-80cc.
Frequency of menses 24 days (0.5%) to 35 days (0.9%) Age 25, 40% are between 25 and 28 days Age 25-35, 60% are between 25 and 28 days Teens and women over 40 s cycles may be longer apart Duration of menses
More informationWhat is endometrial cancer?
Uterine cancer What is endometrial cancer? Endometrial cancer is the growth of abnormal cells in the lining of the uterus. The lining is called the endometrium. Endometrial cancer usually occurs in women
More informationSummary CHAPTER 1. Introduction
Summary This thesis aims to evaluate the diagnostic work-up in postmenopausal women presenting with abnormal vaginal bleeding. The Society of Dutch Obstetrics and Gynaecology composed a guideline, which
More informationbleeding Studies naar de diagnostiek van endom triumcarcinoom bij vrouwen met postm nopauzaal bloedverlies. Studies on the
Studies on the diagnosis of endometria cancer in women with postmenopausal bleeding. Studies naar de diagnostiek va endometriumcarcinoom bij vrouwen m postmenopauzaal bloedverlies. Studies on the diagnosis
More informationCancer A Superficial Introduction
Cancer A Superficial Introduction Gabor Fichtinger, Queen s University Cancer some definitions Medical term: malignant neoplasm Class of diseases in which a group of cells display: uncontrolled growth
More informationProf. Dr. Aydın ÖZSARAN
Prof. Dr. Aydın ÖZSARAN Adenocarcinomas of the endometrium Most common gynecologic malignancy in developed countries Second most common in developing countries. Adenocarcinomas, grade 1 and 2 endometrioid
More informationSaid Saleh. Department of Obstetrics and Gynecology, Faculty of Medicine, Menoufia University, Menoufia, Egypt
ARC Journal of Gynecology and Obstetrics Volume 1, Issue 2, 2016, PP 7-12 ISSN No. (Online) 2456-0561 http://dx.doi.org/10.20431/2456-0561.0102003 www.arcjournals.org Efficacy and Acceptability of two
More informationGynaecological Oncology Cases
Gynaecological Oncology Cases 1. Tamoxifen and the endometrium 2. Cancer and the older woman Dr Julie M Lamont Consultant Gynaecological Oncologist Epworth Freemasons Hospital 21 st April 2015 Mrs FS 66
More informationCervical Cancer - Suspected
Cervical Cancer - Suspected Presentation for patients Asymptomatic presentation Symptomatic presentation History and examination Consider differential diagnoses RED FLAG! Cervix appears normal after examination
More informationENDOMETRIAL CANCER Updated Apr 2017 by: Dr. Jenny Ko (Medical Oncologist, Abbotsford Cancer Centre)
ENDOMETRIAL CANCER Updated Apr 2017 by: Dr. Jenny Ko (Medical Oncologist, Abbotsford Cancer Centre) Source: UpToDate 2017, ASCO/CCO/Alberta provincial guidelines, NCCN Reviewed by: Dr. Sarah Glaze (Gynecologic
More informationShina Oranratanaphan, Tarinee Manchana*, Nakarin Sirisabya
Comparison of Synchronous Endometrial and Ovarian Cancers versus Primary with Metastasis RESEARCH COMMUNICATION Clinicopathologic Variables and Survival Comparison of Patients with Synchronous Endometrial
More informationCorrelation of Endometrial Thickness with the Histopathological Pattern of Endometrium in Postmenopausal Bleeding
DOI 10.1007/s13224-014-0627-z ORIGINAL ARTICLE Correlation of Endometrial Thickness with the Histopathological Pattern of Endometrium in Postmenopausal Bleeding Singh Pushpa Dwivedi Pooja Mendiratta Shweta
More informationEndometrial line thickness in different conditions.
Endometrial line thickness in different conditions 1 Endometrial thickens in response to Rising estrogen levels during the menstrual cycle and then shedding endometrial at the times of menses 2 The thickens
More informationPORTEC-4. Patient seqnr. Age at inclusion (years) Hospital:
May 2016 Randomisation Checklist Form 1, page 1 of 2 Patient seqnr. Age at inclusion (years) Hospital: Eligible patients should be registered and randomised via the Internet at : https://prod.tenalea.net/fs4/dm/delogin.aspx?refererpath=dehome.aspx
More informationStaging and Treatment Update for Gynecologic Malignancies
Staging and Treatment Update for Gynecologic Malignancies Bunja Rungruang, MD Medical College of Georgia No disclosures 4 th most common new cases of cancer in women 5 th and 6 th leading cancer deaths
More informationAdjuvant Therapies in Endometrial Cancer. Emma Hudson
Adjuvant Therapies in Endometrial Cancer Emma Hudson Endometrial Cancer Most common gynaecological cancer Incidence increasing in Western world 1-2% cancer deaths 75% patients postmenopausal 97% epithelial
More information5 Mousa Al-Abbadi. Ola Al-juneidi & Obada Zalat. Ahmad Al-Tarefe
5 Mousa Al-Abbadi Ola Al-juneidi & Obada Zalat Ahmad Al-Tarefe Abnormal Uterine Bleeding (AUB) AUB is a very common scenario or symptom where women complain of menorrhagia (heavy and/or for long periods),
More informationIndex. Cytoplasm, nonepithelial malignant tumor features 70
Accurette device 23 Adenosarcoma, differential diagnosis 80, 81 Arias-Stella reaction 65 Atypical endocervical cells 8 Atypical endometrial cells 8 Atypical glandular cells (AGC) 8, 9 Atypical glandular
More informationFactors predictive of myoinvasion in cases of Complex Atypical Hyperplasia diagnosed on endometrial biopsy or curettage
Factors predictive of myoinvasion in cases of Complex Atypical Hyperplasia diagnosed on endometrial biopsy or curettage Jessica Johns, MD Jeffrey Killeen, MD Robert Kim, MD Hyeong Jun Ahn, PhD None Disclosures
More informationFERTILITY SPARING IN ENDOMETRIAL CANCER
FERTILITY SPARING IN ENDOMETRIAL CANCER Prof. Dr. Bülent Özçelik Erciyes University Medical Faculty Department of Obstetrics and Gynecology Gynecologic Oncology Unit Endometrial Cancer Most frequent gynecologic
More informationand endometrial cancers
Diagnostic procedures for cervical and endometrial cancers Gynecological Cancer Centre University Hospital Basel Viola Heinzelmann-Schwarz MD FMH FRANZCOG CORT(GO) Diagnostic procedures for cervical cancers
More informationBioengineering and World Health. Lecture Twelve
Bioengineering and World Health Lecture Twelve Four Questions What are the major health problems worldwide? Who pays to solve problems in health care? How can technology solve health care problems? How
More informationPRE TEST CERVICAL SCREENING MANAGEMENT COLPOSCOPY PATHOLOGIC DIAGNOSIS AND TREATMENT
PRE TEST CERVICAL SCREENING MANAGEMENT COLPOSCOPY PATHOLOGIC DIAGNOSIS AND TREATMENT QUESTION #1 WHICH OF THE FOLLOWING IS NOT A RISK FACTOR FOR CERVICAL CANCER? A. HIGH RISK HPV B. CIGARETTE SMOKING C.
More informationAbnormal Uterine Bleeding. Richard Dover Specialist gynaecologist
Abnormal Uterine Bleeding Richard Dover Specialist gynaecologist A pragmatic guide. Wide topic range What s not coming up Precocious puberty Menorrhagia well maybe just a little Topics Adolescents IMB
More informationPALM-COEIN: Your AUB Counseling Guide
PALM-COEIN: Your AUB Counseling Guide 10 million+ Treat the cause, not the symptom In the U.S, more than 10 million women between the ages of 35 and 49 are affected by AUB 1 Diagnosis Cause Structural
More informationNewton Wellesley Hospital 2013
Newton Wellesley Hospital 20 Standard 4.6 Assessment and Evaluation of Treatment Planning Endometrial Cancer Each year a physician member of the cancer committee conducts a study to ensure that diagnostic
More informationAUB. Postmenopausal. Approximately 1 of every 8 postmenopausal. Rule out endometrial cancer first OBG COVER ARTICLE
OBG MANAGEMENT COVER ARTICLE Postmenopausal AUB Rule out endometrial cancer first When a postmenopausal woman presents with abnormal uterine bleeding, endometrial cancer is the biggest concern. But a host
More informationWendy L Frankel. Chair and Distinguished Professor
1 Wendy L Frankel Chair and Distinguished Professor Case 1 59 y/o woman Abdominal pain No personal or family history of cancer History of colon polyps Colonoscopy Polypoid rectosigmoid mass Biopsy 3 4
More informationMenstrual Disorders & Ambulatory Gynaecology
Menstrual Disorders & Ambulatory Gynaecology Mr. Nagui Lewis Aziz M B, CH B, FRCOG Consultant Gynaecologist The Royal Oldham Hospital 01/09/2018 Heavy menstrual bleeding (HMB ) is a common problem responsible
More informationFemale genital tract II.
Female genital tract II. Pathology of the uterine corpus Lilla Madaras 2 nd Department Of Pathology Semmelweis University Budapest 9 th April 2018 Anatomy 2 The normal endometrium Histology Regulation
More informationMenopause and Cancer risk; What to do overcome the risks? Fatih DURMUŞOĞLU,M.D
Menopause and Cancer risk; What to do overcome the risks? Fatih DURMUŞOĞLU,M.D Menopause and Cancer How does menopause affect a woman s cancer risk? Ø Menopause does not cause cancer.but risk of developing
More informationPre-operative Evaluation and Implications
Pre-operative Evaluation and Implications Michal Zikan Gynecologic Oncology Center Charles University in Prague, First Faculty of Medicine No recommendation for screening of EC (HNPCC annual biopsies starting
More informationTOC NCCN Categories of Evidence and Consensus Category 1: Based upon high-level evidence, there is uniform NCCN consensus that the intervention is appropriate. Category 2A: Based upon lower-level evidence,
More informationIMS QUIZ on Perimenopausal Bleeding, Bangalore Menopause Society marks
IMS QUIZ on Perimenopausal Bleeding, Bangalore Menopause Society 19.11.2017 100 marks Fill in the blanks 20 marks 1. Gestrinone is a synthetic derivative of 19-nortestosterone steroid nucleus 2. Risk of
More informationFemale Genital Tract Lab. Dr. Nisreen Abu Shahin Assistant Professor of Pathology University of Jordan
Female Genital Tract Lab Dr. Nisreen Abu Shahin Assistant Professor of Pathology University of Jordan Ovarian Pathology A 20-year-old female presented with vague left pelvic pain. Pelvic exam revealed
More informationOncology 101. Cancer Basics
Oncology 101 Cancer Basics What Will You Learn? What is Cancer and How Does It Develop? Cancer Diagnosis and Staging Cancer Treatment What is Cancer? Cancer is a group of more than 100 different diseases
More informationDr. Nancy Van Eyk Associate Professor, Dalhousie University Chief of Gynaecology, IWK Health Centre
Dr. Nancy Van Eyk Associate Professor, Dalhousie University Chief of Gynaecology, IWK Health Centre AUB Outline Terminology Classification/Etiology Assessment Treatment Referral to Gynaecology U c pt 4
More informationResearch. Breast cancer represents a major
Research GENERAL GYNECOLOGY Gynecologic conditions in participants in the NSABP breast cancer prevention study of tamoxifen and raloxifene (STAR) Carolyn D. Runowicz, MD; Joseph P. Costantino, DrPH; D.
More informationsurgical staging g in early endometrial cancer
Risk adapted d approach to surgical staging g in early endometrial cancer Leon Massuger University Medical Centre St Radboud Nijmegen, The Netherlands Doing nodes Yes Yes Yes No No No 1957---------------------------
More informationGynecologic Malignancies. Kristen D Starbuck 4/20/18
Gynecologic Malignancies Kristen D Starbuck 4/20/18 Outline Female Cancer Statistics Uterine Cancer Adnexal Cancer Cervical Cancer Vulvar Cancer Uterine Cancer Endometrial Cancer Uterine Sarcoma Endometrial
More informationMichael G. Kelly, MD Gynecologic Oncologist University of Colorado Cancer Center
Michael G. Kelly, MD Gynecologic Oncologist University of Colorado Cancer Center 50 yo healthy postmenopausal female with BMI = 35 with screening PAP smear = AGUS. What is the next step? (1) Colposcopy
More informationRelapse Patterns and Outcomes Following Recurrence of Endometrial Cancer in Northern Thai Women
DOI:http://dx.doi.org/10.7314/APJCP.2015.16.9.3861 Relapse Patterns and Outcomes Following Recurrence of Endometrial Cancer in Northern Thai Women RESEARCH ARTICLE Relapse Patterns and Outcomes Following
More informationRESEARCH COMMUNICATION
RESEARCH COMMUNICATION Clinicopathologic Analysis of Women with Synchronous Primary Carcinomas of the Endometrium and Ovary: 10- Year Experience from Chiang Mai University Hospital Jiraprapa Natee 1 *,
More informationNon-contraceptive Uses of the Levonorgestrel Intrauterine Device Elena Gates, MD http://www.mirena-us.com/pvs1/pri/whatisframe.html Progestin levels with LNG- IUS Lower plasma levels Mirena 150-200 pg/ml
More informationInherited Ovarian Cancer Diagnosis and Prevention
Inherited Ovarian Cancer Diagnosis and Prevention Dr. Jacob Korach - Deputy director Gynecologic Oncology (past chair - Israeli Society of Gynecologic Oncology) Prof. Eitan Friedman - Head, Oncogenetics
More informationGYNECOLOGIC MALIGNANCIES: Ovarian Cancer
GYNECOLOGIC MALIGNANCIES: Ovarian Cancer KRISTEN STARBUCK, MD ROSWELL PARK CANCER INSTITUTE DEPARTMENT OF SURGERY DIVISION OF GYNECOLOGIC ONCOLOGY APRIL 19 TH, 2018 Objectives Basic Cancer Statistics Discuss
More informationOVARIAN CANCER Updates in Screening, Early Detection and Prevention
UW MEDICINE SUSAN PATRICIA TECK MEMORIAL LECTURE October 2017 OVARIAN CANCER Updates in Screening, Early Detection and Prevention BARBARA GOFF, MD Seattle Gynecologic Society March 2018 OVARIAN CANCER
More informationManagement of Abnormal Uterine Bleeding. Julie Strickland MD, MPH University of Missouri Kansas City Department of Obstetrics and Gynecology
Management of Abnormal Uterine Bleeding Julie Strickland MD, MPH University of Missouri Kansas City Department of Obstetrics and Gynecology AUB Abnormal uterine bleeding (AUB): fairly broad term referring
More informationHemoglobin A1c and the relationship to stage and grade of endometrial cancer
DOI 10.1007/s00404-012-2455-7 GYNECOLOGIC ONCOLOGY Hemoglobin A1c and the relationship to stage and grade of endometrial cancer Erin E. Stevens Sarah Yu Melanie Van Sise Tana Shah Pradhan Vanessa Lee Michael
More informationPrevention, Diagnosis and Treatment of Gynecologic Cancers
Prevention, Diagnosis and Treatment of Gynecologic Cancers Jubilee Brown MD and Pamela T. Soliman MD, MPH Department of Gynecologic Oncology and Reproductive Medicine University of Texas MD Anderson Cancer
More informationUnderstanding and Managing Lynch Syndrome
Understanding and Managing Lynch Syndrome Princess Margaret For women who may have Lynch syndrome and their family members Please visit the UHN Patient Education website for more health information: www.uhnpatienteducation.ca
More informationARROCase: Locally Advanced Endometrial Cancer
ARROCase: Locally Advanced Endometrial Cancer Charles Vu, MD (PGY-3) Faculty Advisor: Peter Y. Chen, MD, FACR Beaumont Health (Royal Oak, MI) November 2016 Case 62yo female with a 3yr history of vaginal
More informationIs It Time To Implement Ovarian Cancer Screening?
Is It Time To Implement Ovarian Cancer Screening? Prof Dr Samet Topuz Istanbul Medıcal Faculty Department Of Obstetrics and Gynecology ESGO Prevention in Gynaecological Malignancies September 08 2016 Antalya
More informationManagement of Endometrial Hyperplasia
Management of Endometrial Hyperplasia Green-top Guideline No. 67 RCOG/SGE Joint Guideline February 2016 Management of Endometrial Hyperplasia This is the first edition of this guideline.this is a joint
More informationEndometrial Cancer. Saudi Gynecology Oncology Group (SGOG) Gynecological Cancer Treatment Guidelines
Saudi Gynecology Oncology Group (SGOG) Gynecological Cancer Treatment Guidelines Endometrial Cancer Emad R. Sagr, MBBS, FRCSC Consultant Gynecology Oncology Security forces Hospital, Riyadh Epidemiology
More informationManagement of endometrial abnormalities in postmenopausal women, an individualized approach Breijer, M.C.
UvA-DARE (Digital Academic Repository) Management of endometrial abnormalities in postmenopausal women, an individualized approach Breijer, M.C. Link to publication Citation for published version (APA):
More informationChapter 2: Initial treatment for endometrial cancer (including histologic variant type)
Chapter 2: Initial treatment for endometrial cancer (including histologic variant type) CQ01 Which surgical techniques for hysterectomy are recommended for patients considered to be stage I preoperatively?
More information29 Cancer of the Uterine Corpus
29 Cancer of the Uterine Corpus Robbert Soeters INTRODUCTION Malignancies affecting the uterine corpus are endometrial adenocarcinoma and uterine sarcomas. ENDOMETRIAL ADENOCARCINOMA Endometrial adenocarcinoma
More informationTable E1. Standardized Mortality Ratios for Total and Specific Causes of Death Parameter Radiologists Psychiatrists No. of Deaths
RSNA, 2016 10.1148/radiol.2016152472 Table E1. Standardized Mortality Ratios for Total and Specific Causes of Death Parameter Radiologists Psychiatrists No. of Deaths Observed/Expected No. of Deaths Observed/Expected
More informationAbnormal uterine bleeding:
Primary Care Women s Health Forum 16th June 2010 Abnormal uterine bleeding: The University Of Birmingham T Justin Clark MD (Hons), MRCOG Consultant Obstetrician and Gynaecologist Birmingham Women s Hospital
More informationGynaecology Cancer Red Flags. Dr Dina Bisson Consultant Obstetrician and Gynaecologist Southmead Hospital North Bristol NHS Trust 27 April 2017
Gynaecology Cancer Red Flags Dr Dina Bisson Consultant Obstetrician and Gynaecologist Southmead Hospital North Bristol NHS Trust 27 April 2017 Gynaecological Cancers Endometrial Cancer Ovarian Cancer Cervical
More informationAdenocarcinoma of the Endometrium: An Institutional Review
Pieter Baltens, 1580. Feast of St. George. From the collection of Dr. Gordon and Adele Gilbert of St. Petersburg, Florida. Adenocarcinoma of the Endometrium: An Institutional Review Denis Cavanagh, MD;
More informationCollection of Recorded Radiotherapy Seminars
IAEA Human Health Campus Collection of Recorded Radiotherapy Seminars http://humanhealth.iaea.org Conservative Treatment of Invasive Bladder Cancer Luis Souhami, MD Professor Department of Radiation Oncology
More information2009 USCAP Gyn Pathology Evening Session Case #3. Richard J. Zaino, MD Hershey Medical Center Penn State University Hershey, PA
2009 USCAP Gyn Pathology Evening Session Case #3 Richard J. Zaino, MD Hershey Medical Center Penn State University Hershey, PA rzaino@psu.edu Clinical history Middle aged woman with an exophytic mass of
More informationLaparoscopic Management of Early Stage Endometrial Cancer. B. Rabischong, M. Canis, G. Le Bouedec, C. Pomel, J.L Achard, J. Dauplat, G.
Laparoscopic Management of Early Stage Endometrial Cancer B. Rabischong, M. Canis, G. Le Bouedec, C. Pomel, J.L Achard, J. Dauplat, G. Mage Early Stage of Endometrial Cancer most of cases diagnosed (clinical
More informationEndometrial Cancer in Thai Women aged 45 years or Younger
RESEARCH COMMUNICATION Endometrial Cancer in Thai Women aged 45 years or Younger Jitti Hanprasertpong 1 *, Suchada Sakolprakraikij 1, Alan Geater 2 Abstract The aim of this retrospective study was to clarify
More informationPathology of the female genital tract
Pathology of the female genital tract Common illnesses of the female genital tract Before menarche Developmental anomalies Tumors (ovarial teratoma) Amenorrhea Fertile years PCOS, ovarian cysts Endometriosis
More informationENDOMETRIAL CANCER: A GUIDE FOR PATIENTS
ENDOMETRIAL CANCER: A GUIDE FOR PATIENTS PATIENT INFORMATION BASED ON ESMO CLINICAL PRACTICE GUIDELINES This guide for patients has been prepared by Reliable Cancer Therapies (RCT) as a service to patients,
More informationSubject Index. Cavaterm, endometrial ablation complications 146, 150 contraindications 152 cost analysis compared with hysterectomy
OOOOOOOOOOOOOOOOOOOOOOOOOOOOOO Subject Index Abnormal uterine bleeding, see also Adenomyosis, Endometrial cancer, Menorrhagia dilatation and curettage 21, 22, 25 hysteroscopy of premenopausal women anesthesia
More informationIf you do not have time for the entire presentation refer to the following table of contents. To navigate through the slides, right click on your
Welcome This is an online version of a lecture given by Dr Keith Merritt on gyn cancers. Its purpose is to help women become more aware of early symptoms, risk factors, screening strategies and the importance
More informationEpithelial Ovarian Cancer 8/2/2013. Tu-be or Not Tu-be: Is the Fallopian Tube the Source of Ovarian Cancer?
Tu-be or Not Tu-be: Is the Fallopian Tube the Source of Ovarian Cancer? Ann E. Smith Sehdev, MD Director, Center for Gynecologic Pathology Cascade Pathology, Portland, Oregon Ann E. Smith Sehdev has no
More informationGynecologic Oncology update
Gynecologic Oncology update Park City Utah Postgraduate Course in the Department of Obstetrics and Gynecology University of Utah/Huntsman Cancer Institute Andrew P. Soisson, MD Division of Gynecologic
More informationSurgery to Reduce the Risk of Ovarian Cancer. Information for Women at Increased Risk
Surgery to Reduce the Risk of Ovarian Cancer Information for Women at Increased Risk Centre for Genetics Education NSW Health 2017 The Centre for Genetics Education NSW Health Level 5 2C Herbert St St
More informationConcurrent Endometrial Carcinoma in Patients with a Curettage Diagnosis of Endometrial Hyperplasia
ORIGINAL ARTICLE Concurrent Endometrial Carcinoma in Patients with a Curettage Diagnosis of Endometrial Hyperplasia Yu-Li Chen, 1 Wen-Fang Cheng, 1,2 Ming-Chieh Lin, 3 Chia-Yen Huang, 1 Chang-Yao Hsieh,
More informationProphylactic Mastectomy State of the Art
Memorial Sloan-Kettering Cancer Center 1275 York Avenue, New York, NY 10065 6 th Brazilian Breast Cancer Conference Sao Paulo, Brazil 9 March 2012 Prophylactic Mastectomy State of the Art Monica Morrow
More informationWinship Cancer Institute of Emory University Optimizing First Line Treatment of Advanced Ovarian Cancer
Winship Cancer Institute of Emory University Optimizing First Line Treatment of Advanced Ovarian Cancer Ira R. Horowitz, MD, SM, FACOG, FACS John D. Thompson Professor and Chairman Department of Gynecology
More informationMedical Management of Fibroids Esmya. Dr Paula Briggs Consultant in Sexual and Reproductive Health
Medical Management of Fibroids Esmya Dr Paula Briggs Consultant in Sexual and Reproductive Health Treatment options for Uterine Fibroids ESMYA Selective Uterine Artery Embolisation Fibroid ablation (hysteroscopic
More informationCase Scenario 1. History
History Case Scenario 1 A 53 year old white female presented to her primary care physician with post-menopausal vaginal bleeding. The patient is not a smoker and does not use alcohol. She has no family
More informationProtect & Detect: What Women should Know about cancer. The American College of Obstetricians and Gynecologists
Protect & Detect: What Women should Know about cancer The American College of Obstetricians and Gynecologists A Message From ACOG President Kenneth L. Noller, MD Dr. Noller is the Louis E. Phaneuf professor
More information